Predictive Value of Liver Enzymes and Inflammatory Biomarkers for the Severity of Liver Fibrosis Stage in HIV/HCV Co-Infected Patients

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Charpentier, Charlotte ^a   Champenois, Karen ^b   Gervais, Anne ^a   Landman, Roland ^a   Joly, Véronique ^a   Le Gac, Sylvie ^a   Larrouy, Lucile ^a   Damond, Florence ^a   Brun Vézinet, Françoise ^a   Descamps, Diane ^a   Yazdanpanah, Yazdan ^a  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD14 ANTIGEN; INTERLEUKIN 6; LIVER ENZYME; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PATIENT ASSESSMENT; PREDICTIVE VALUE; THROMBOCYTE COUNT;

ALANINE TRANSAMINASE; ANTIGENS, CD14; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; COINFECTION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERLEUKIN-6; LIVER CIRRHOSIS; LOGISTIC MODELS;

EID: 84875090177     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059205     Document Type: Article

References (10)

1. Kalayjian RC, Machekano RN, Rizk N, Robbins GK, Gandhi RT, et al. (2010) Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J Infect Dis 201: 1796-1805.
2. Sandler NG, Wand H, Roque A, Law M, Nason MC, et al. (2011) Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 203: 780-790.
3. Marchetti G, Cozzi-Lepri A, Merlini E, Bellistrì GM, Castagna A, et al. (2011) Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS 25: 1385-1394.
4. Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, et al. (2011) Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 141: 1220-1230.
5. Rodger AJ, Fox Z, Lundgren JD, Kuller LH, Boesecke C, et al. (2009) Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 200: 973-983.
6. Boulware DR, Hullsiek KH, Puronen CE, Rupert A, Baker JV, et al. (2011) Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis 203: 1637-1646.
7. Thein HH, Yi Q, Dore GJ, Krahn MD, (2008) Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 22: 1979-1991.
8. Macías J, von Wichmann M, Rivero A, Tellez F, Merino D, et al. (2010) Fast liver damage progression in HIV/HCV-co-infected patients in spite of effective HAART. [Abstract #659]. In: Program and Abstract of the 17th Conference on Retroviruses and Opportunistic Infections; 16-19 February 2010; San Francisco, USA.
9. Vermehren J, Vermehren A, Mueller A, Carlebach A, Lutz T, et al. (2012) Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers. BMC Gastroenterol 12: 27.
10. Cartón JA, Collazos J, de la Fuente B, García-Alcalde ML, Suarez-Zarracina T, et al. (2011) Factors associated with liver fibrosis in intravenous drug users coinfected with HIV and HCV. Antivir Ther 16: 27-35.